A citation-based method for searching scientific literature

Renata Rodrigues da Cunha Colombo Bonadio, Rodrigo Nogueira Fogace, Vanessa Costa Miranda, Maria Del Pilar Estevez Diz. Clinics (Sao Paulo) 2018
Times Cited: 29



. Nature 2011
Times Cited: 4670




List of shared articles



Times cited

EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression.
Stephanie Lheureux, Ana Oaknin, Swati Garg, Jeffrey P Bruce, Ainhoa Madariaga, Neesha C Dhani, Valerie Bowering, Justin White, Sarah Accardi, Qian Tan,[...]. Clin Cancer Res 2020
13


Prevalence of Tissue BRCA Gene Mutation in Ovarian, Fallopian Tube, and Primary Peritoneal Cancers: A Multi-Institutional Study.
Arb-Aroon Lertkhachonsuk, Prapaporn Suprasert, Tarinee Manchana, Thannaporn Kittisiam, Nuttavut Kantathavorn, Tharintorn Chansoon, Surapan Khunamornpong, Natkrita Pohthipornthawat, Siriwan Tangjitgamol, Taksa Luasiripanthu,[...]. Asian Pac J Cancer Prev 2020
1

Exploring the Clinical Impact of Predictive Biomarkers in Serous Ovarian Carcinomas.
Cécile Le Page, Jacqueline Chung, Kurosh Rahimi, Martin Köbel, Diane Provencher, Anne-Marie Mes-Masson. Curr Drug Targets 2020
0

Educational Case: High-Grade Serous Carcinoma of the Ovary.
Sophia Bunde, Swikrity Upadhyay Baskota, Jeffrey Fine, Samer Khader. Acad Pathol 2021
0



Aldehyde dehydrogenase inhibitors promote DNA damage in ovarian cancer and synergize with ATM/ATR inhibitors.
Edward Grimley, Alexander J Cole, Thong T Luong, Stacy C McGonigal, Sarah Sinno, Dongli Yang, Kara A Bernstein, Ronald J Buckanovich. Theranostics 2021
1